116757-62-1 Usage
Explanation
This is an alternative name for the compound, which is derived from its structure and functional groups.
Explanation
The (3R)designation indicates that this compound is a specific stereoisomer with the R configuration at the chiral center. Stereoisomers are molecules with the same molecular formula but different spatial arrangements of atoms.
Explanation
A chiral center is an atom (usually carbon) that is bonded to four different groups, resulting in different spatial arrangements of the molecule. In this case, the chiral center is at the 3rd carbon of the butanol chain.
Explanation
This compound is used as an intermediate in the synthesis of various products, including pharmaceuticals, agrochemicals, and fragrances.
Explanation
Due to its chemical properties, 1-Butanol, 3-(phenylmethoxy)-, (3R)can act as a solvent in various chemical processes, facilitating reactions and improving efficiency.
Explanation
Scientists are researching the potential biological and pharmacological activities of this compound, which could lead to new discoveries and applications in medicine and other fields.
Stereoisomer
(3R)-
Chiral Center
Present
Applications
Pharmaceutical, agrochemical, and fragrance production
Solvent
Used in chemical processes
Organic Synthesis
Potential applications
Research
Biological and pharmacological activities
Check Digit Verification of cas no
The CAS Registry Mumber 116757-62-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,6,7,5 and 7 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 116757-62:
(8*1)+(7*1)+(6*6)+(5*7)+(4*5)+(3*7)+(2*6)+(1*2)=141
141 % 10 = 1
So 116757-62-1 is a valid CAS Registry Number.
116757-62-1Relevant articles and documents
First Synthesis and Characterization of Stereoisomers of Choleretic Drug Dihydroxydibutylether
Yue, Qiming,Zhao, Yi,Sun, Baohou,Hai, Li,Guo, Li,Wu, Yong
, p. 1145 - 1152 (2015)
Dihydroxydibutylether (DHBE) is a choleretic drug used for the treatment of gallstone and hepatic disorders due to its choleretic activity and hepatoprotective action. The drug is a mixture of three regioisomers. The main regioisomer 3-(3-hydroxylbutoxy)-
MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME
-
Page/Page column 124, (2019/01/06)
Multibiotic agents are disclosed. The multibiotic agents may contain two or more moieties linked through bonds cleavable in vivo. The bonds cleavable in vivo can be ester bonds, amide bonds, azo bonds, glycosidic bonds, carbonate linkers, or carbamate linkers. The moieties can be alcohol cores, amine cores, and/or acyls. Also disclosed are compositions containing multibiotic agents and methods of using the multibiotic agents.
Novel, Acyclically Substituted Furopyrimidine Derivatives and Use Thereof
-
Page/Page column 35-36, (2009/12/28)
The present application relates to novel, acyclically substituted furopyrimidine derivatives, methods for their production, their use for the treatment and/or prophylaxis of diseases and their use for the production of medicinal products for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular diseases.
